Citations

Showing 10 of 108094 citations.

MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells
Tran, Mai H. , Quin, Rachel J., Xing, Pei‐Xiang , Gendler, Sandra , Hart, Derek N.J. , Wykes, Michelle , MacDonald, Kelli P. A. , McGuckin, Michael A.

Mayo Clinic

Journal of Leukocyte Biology | September 28, 2022 | Volume: 72 | Issue: 4 | Pages: 692-701

10.1189/jlb.72.4.692 Get It

AbstractThe MUC1 mucin (CD227) is a cell surface mucin originally thought to be restricted to epithelial tissues. We report that CD227 is expressed on human blood dendritic cells (DC) and monocyte-derived DC following in vitro activation. Freshly isolated murine splenic DC had very low levels of CD227; however, all DC expressed CD227 following in vitro culture. In the mouse spleen, CD227 was seen on clusters within the red pulp and surrounding the marginal zone in the white pulp. Additionally, we confirm CD227 expression by activated human T cells and show for the first time that the CD227 cytoplasmic domain is tyrosine-phosphorylated in activated T cells and DC and is associated with other phosphoproteins, indicating a role in signaling. The function of CD227 on DC and T cells requires further elucidation.
Treatment of giant intracranial aneurysms using the Pipeline flow-diverting stent: Long-term results from the International Retrospective Study of the Pipeline Embolization Device (IntrePED) study
Grandhi, Ramesh , Ravindra, Vijay M. , Kallmes, David F. , Hanel, Ricardó A. , Lylyk, Pedro , Hanel, Ricardo A , Grandhi, Ramesh , Lopes, Demetrius K.

Mayo Clinic

Interventional Neuroradiology | September 28, 2022 | Volume: 30 | Issue: 2 | Pages: 218-226

10.1177/15910199221123282 | PMID 36168255 Get It

Background Traditional endovascular treatments of giant intracranial aneurysms are associated with high rates of complications and retreatment. Our objective was to examine the safety and long-term efficacy of the Pipeline Embolization Device for treatment of these aneurysms. Methods This retrospective study using the IntrePED database included all patients with giant intracranial aneurysms treated with the Pipeline device between July 2008 and February 2013. Efficacy outcomes were stratified by using the Raymond-Roy Occlusion Classification. Predefined safety outcomes included spontaneous rupture of the target aneurysm; ipsilateral intracranial hemorrhage; ischemic stroke; parent artery stenosis; and sustained cranial neuropathy. Results Sixty-six embolizations were performed to treat 63 giant intracranial aneurysms (including 2 ruptured): 49 (77.8%) in the anterior and 14 (22.2%) in the posterior circulation. The median follow-up was 22.4 (0.1–60.5) months. Class I angiographic occlusion was achieved in 72.0% (36/50). The neurological morbidity/mortality rate was 23.8% (15/63), with higher rates in the posterior circulation than in the anterior circulation (22.4% vs. 28.6%). Among seven deaths, five had neurological causes. The procedure-related neurological morbidity and mortality rates were 22.7% (15/66) and 7.6% (5/66), respectively. The spontaneous rupture rate was 4.5% (3/66). Two spontaneous ruptures (1 death), 4/4 postprocedural intracranial hemorrhages, and 6/9 ischemic events occurred within 30 days. In-stent stenosis and new-onset cranial neuropathy were not observed during the angiographic follow-up period. Conclusions Although procedure-related neurological morbidity/mortality rates were not insignificant, this study confirms the feasibility and long-term efficacy of the Pipeline Embolization Device to treat giant intracranial aneurysms.
Anoctamin 5 (ANO5) Muscle Disorders: A Narrative Review
Soontrapa, Pannathat , Liewluck, Teerin , Liewluck, T

Mayo Clinic

Genes | September 27, 2022 | Volume: 13 | Issue: 10 | Pages: 1736

10.3390/genes13101736 | PMID 36292621 Get It

Anoctaminopathy-5 refers to a group of hereditary skeletal muscle or bone disorders due to mutations in the anoctamin 5 (ANO5)-encoding gene, ANO5. ANO5 is a 913-amino acid protein of the anoctamin family that functions predominantly in phospholipid scrambling and plays a key role in the sarcolemmal repairing process. Monoallelic mutations in ANO5 give rise to an autosomal dominant skeletal dysplastic syndrome (gnathodiaphyseal dysplasia or GDD), while its biallelic mutations underlie a continuum of four autosomal recessive muscle phenotypes: (1). limb–girdle muscular dystrophy type R12 (LGMDR12); (2). Miyoshi distal myopathy type 3 (MMD3); (3). metabolic myopathy-like (pseudometabolic) phenotype; (4). asymptomatic hyperCKemia. ANO5 muscle disorders are rare, but their prevalence is relatively high in northern European populations because of the founder mutation c.191dupA. Weakness is generally asymmetric and begins in proximal muscles in LGMDR12 and in distal muscles in MMD3. Patients with the pseudometabolic or asymptomatic hyperCKemia phenotype have no weakness, but conversion to the LGMDR12 or MMD3 phenotype may occur as the disease progresses. There is no clear genotype–phenotype correlation. Muscle biopsy displays a broad spectrum of pathology, ranging from normal to severe dystrophic changes. Intramuscular interstitial amyloid deposits are observed in approximately half of the patients. Symptomatic and supportive strategies remain the mainstay of treatment. The recent development of animal models of ANO5 muscle diseases could help achieve a better understanding of their underlying pathomechanisms and provide an invaluable resource for therapeutic discovery.
Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3
Nunno, Vincenzo Di , Asioli, Sofia , Conti, Alfredo , Balestrini, Damiano , Tosoni, Alicia , Di Nunno, Vincenzo , Asioli, Sofia , Conti, Alfredo , Balestrini, Damiano , Giannini, Caterina , Furtner, Julia

Mayo Clinic

Cancers | September 27, 2022 | Volume: 14 | Issue: 19 | Pages: 4689

10.3390/cancers14194689 | PMID 36230612 Get It

Background: Meningiomas are the most common primary central nervous system malignancies accounting for 36% of all intracranial tumors. However, only 1% of meningioma is classified as malignant (anaplastic) meningioma. Due to their rarity, clinical management of these tumors presents several gaps. Methods: We carried out a narrative review aimed to investigate current knowledge of anaplastic meningioma focusing on their pathological and radiological diagnosis, molecular assessment, and loco-regional and systemic management. Results: The most frequent genetic alteration occurring in meningioma is the inactivation in the neurofibromatosis 2 genes (merlin). The accumulation of copy number losses, including 1p, 6p/q, 10q, 14q, and 18p/q, and less frequently 2p/q, 3p, 4p/q, 7p, 8p/q, and 9p, compatible with instability, is restricted to NF2 mutated meningioma. Surgery and different RT approaches represent the milestone of grade 3 meningioma management, while there is a marginal role of systemic therapy. Conclusions: Anaplastic meningiomas are rare tumors, and diagnosis should be suspected and confirmed by trained radiologists and pathologists. Despite the current marginal role of systemic therapy, it is possible that the increasing knowledge of molecular altered pathways of the disease will lead to the development of novel effective systemic treatments.
A New Survival Score for Patients ≥65 Years Assigned to Radiotherapy of Bone Metastases
Rades, Dirk , DELIKANLI, CANSU, Kristiansen, Charlotte , Tvilsted, Søren, Schild, Steven E. , Kristiansen, Charlotte , DELIKANLI, CANSU, Janssen, Stefan

Mayo Clinic

Cancers | September 27, 2022 | Volume: 14 | Issue: 19 | Pages: 4679

10.3390/cancers14194679 | PMID 36230602 Get It

Survival scores are important for personalized treatment of bone metastases. Elderly patients are considered a separate group. Therefore, a specific score was developed for these patients. Elderly patients (≥65 years) irradiated for bone metastases were randomly assigned to the test (n = 174) or validation (n = 174) cohorts. Thirteen factors were retrospectively analyzed for survival. Factors showing significance (p < 0.05) or a trend (p < 0.06) in the multivariate analysis were used for the score. Based on 6-month survival rates, prognostic groups were formed. The score was compared to an existing tool developed in patients of any age. In the multivariate analysis, performance score, tumor type, and visceral metastases showed significance and gender was a trend. Three groups were designed (17, 18–25 and 27–28 points) with 6-month survival rates of 0%, 51%, and 100%. In the validation cohort, these rates were 9%, 55%, and 86%. Comparisons of prognostic groups between both cohorts did not reveal significant differences. In the test cohort, positive predictive values regarding death ≤6 and survival ≥6 months were 100% with the new score vs. 80% and 88% with the existing tool. The new score was more accurate demonstrating the importance of specific scores for elderly patients.
Exploring Antimicrobial Stewardship Influential Interventions on Improving Antibiotic Utilization in Outpatient and Inpatient Settings: A Systematic Review and Meta-Analysis
Sadeq, Ahmed A., AbouKhater, Noha, Conway, Barbara R. , Abdelsalam, Abeer Elmahi, Shamseddine, Jinan M., Nsutebu, Emmanuel , Bond, Stuart , Aldeyab, Mamoon A. , Conway, Barbara R , Abdelsalam, Abeer E, Babiker, Zahir Osman Eltahir , Nsutebu, Emmanuel Fru, Bond, Stuart E , Aldeyab, Mamoon A , Hasan, Syed Shahzad

Mayo Clinic

Antibiotics | September 27, 2022 | Volume: 11 | Issue: 10 | Pages: 1306

10.3390/antibiotics11101306 | PMID 36289964 Get It

Antimicrobial stewardship interventions are targeted efforts by healthcare organizations to optimize antimicrobial use in clinical practice. The study aimed to explore effective interventions in improving antimicrobial use in hospitals. Literature was systemically searched for interventional studies through PubMed, CINAHL, and Scopus databases that were published in the period between January 2010 to April 2022. A random-effects model was used to pool and evaluate data from eligible studies that reported antimicrobial stewardship (AMS) interventions in outpatient and inpatient settings. Pooled estimates presented as proportions and standardized mean differences. Forty-eight articles were included in this review: 32 in inpatient and 16 in outpatient settings. Seventeen interventions have been identified, and eight outcomes have been targeted. AMS interventions improved clinical, microbiological, and cost outcomes in most studies. When comparing non-intervention with intervention groups using meta-analysis, there was an insignificant reduction in length of stay (MD: −0.99; 95% CI: −2.38, 0.39) and a significant reduction in antibiotics’ days of therapy (MD: −2.73; 95% CI: −3.92, −1.54). There were noticeable reductions in readmissions, mortality rates, and antibiotic prescriptions post antimicrobial stewardship multi-disciplinary team (AMS-MDT) interventions. Studies that involved a pharmacist as part of the AMS-MDT showed more significant improvement in measured outcomes than the studies that did not involve a pharmacist.
Assessing Patient-Reported Financial Hardship in Patients With Cancer in Routine Clinical Care
Voleti, Sandeep S. , Warsame, Rahma , Mead‐Harvey, Carolyn , Ailawadhi, Sikander , Jain, Atul , Fonseca, Rafaël , Griffin, Joan M. , Khera, Nandita , Ailawadhi, Sikander , Griffin, Joan M , Fonseca, Rafael , Jain, Atul

Mayo Clinic

JCO Oncology Practice | September 27, 2022 | Volume: 18 | Issue: 11 | Pages: e1839-e1853

10.1200/op.22.00276 | PMID 36166729 Get It

PURPOSE: Financial hardship (FH) in cancer care is a growing challenge for patients, their caregivers, and health care providers with impact on morbidity and mortality. In this study, we report on a standardized approach to describe the prevalence and predictors for FH as part of routine clinical workflow. We also report on the association of FH with survival in our cancer patient population. METHODS: This study includes patients who completed a FH screen at least once between 2018 and 2020. Demographics, disease state, and mortality data were extracted from the medical records. Multivariable logistic regression models were used to examine association of sociodemographic and disease variables with FH. By using propensity score weighting to account for differences in demographic and clinical factors between patients with and without FH, we then fit Cox proportional hazards models to examine the relationship between FH and survival. RESULTS: The study cohort included 31,154 patients. FH was reported by 14% (n = 4,250) of the patients. A significantly higher likelihood of having FH ( P < .001 for all) was reported by racial/ethnic minority patients; those who were unemployed/disabled, single, or divorced; patients from disadvantaged neighborhoods; and those who were self-pay or had government insurance. Older age, being retired, and living farther from the cancer center were associated with significantly less likelihood of endorsing FH. Patients who endorsed FH had a lower survival (hazard ratio for mortality 1.46). CONCLUSION: Our study identified key groups more likely to report FH in a relatively affluent population at a large cancer center and showed an adverse association between FH and survival. Further research is needed to develop clinical care pathways for patients at high risk for worse financial and clinical outcomes.
Understanding Modern Medical Centers: Beyond Simone—Intersectional Maxims for a New Era
Graff, Stephanie L. , Wildes, Tanya M. , Duma, Narjust , Dizon, Don S. , LoConte, Noelle K. , Mitchell, Edith, Murphy, Martina, Perez, Edith A. , Temkin, Sarah M. , Kunz, Pamela L. , Winkfield, Karen M. , Florez, Narjust , Wildes, Tanya , LoConte, Noelle , Graff, Stephanie L , Temkin, Sarah M

Mayo Clinic

Journal of Clinical Oncology | September 27, 2022 | Volume: 41 | Issue: 7 | Pages: 1350-1358

10.1200/jco.22.01060 | PMID 36166718 Get It

DiRA: Discriminative, Restorative, and Adversarial Learning for Self-supervised Medical Image Analysis
Haghighi, Fatemeh , Taher, Mohammad Reza Hosseinzadeh , Gotway, Michael B. , Liang, Jianming

Mayo Clinic

2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) | September 27, 2022 | Volume: No volume available | Issue: No issue available | Pages: 20792-20802

10.1109/cvpr52688.2022.02016 | PMID 36313959 Get It

Similarity-Informed Self-Learning and Its Application on Seismic Image Denoising
Liu, Naihao , Wang, Jiale , Gao, Jinghuai , Chang, Shaojie , Lou, Yihuai

Mayo Clinic

IEEE Transactions on Geoscience and Remote Sensing | September 27, 2022 | Volume: 60 | Issue: No issue available | Pages: 1-13

10.1109/tgrs.2022.3210217 Get It